Effectiveness of an intervention designed to optimize statins use: A primary prevention randomized clinical trial

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Fàbregas, Mireia ^a,b   Berges, Irene ^c   Fina, Francesc ^b   Hermosilla, Eduardo ^b   Coma, Ermengol ^b   Méndez, Leonardo ^b   Medina, Manuel ^b   Calero, Sebastià ^b   Serrano, Elena ^d   Morros, Rosa ^b,e   Monteagudo, Mònica ^b,e   Bolíbar, Bonaventura ^b,e  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b INSTITUT UNIVERSITARI D'INVESTIGACIÓ EN ATENCIÓ PRIMÀRIA JORDI GOL   (Spain)

^c HOSPITAL DE SABADELL   (Spain)

^d Centre d'Atenció Primària Baix A Mar Consell Comarcal Del Garraf Vilanova i la Geltrú   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cardiovascular disease; Clinical practice guidelines; Clinical trial; Electronic health records; Lipid lowering therapy; Prescription adequacy; Prescriptions; Primary health care; Primary prevention

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADAPTIVE BEHAVIOR; ADULT; AGED; CARDIOVASCULAR DISEASES; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STANDARDS; TOTAL QUALITY MANAGEMENT;

ADULT; AGED; CARDIOVASCULAR DISEASES; ELECTRONIC HEALTH RECORDS; FEEDBACK, PSYCHOLOGICAL; FEMALE; GENERAL PRACTITIONERS; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; QUALITY IMPROVEMENT;

EID: 84904074454     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-15-135     Document Type: Article

References (28)

1. The concept of prevention: a good idea gone astray? Starfield B, Hyde J, Gérvas J, Heath I, J Epidemiol Community Health 2008 62 580 583 (Pubitemid 351960218)
2. The Zero-vision: potential side effects of communicating health perfection and zero risk. Fugelli P, Patient Educ Couns 2006 60 267 271 (Pubitemid 43287930)
3. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. Verschuren WMM, Jacobs DR, Bloemberg BPM, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedelijković S, Nissinen A, Toshima H, JAMA 1995 274 131 136
4. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999. Gil M, Martí H, Elosua R, Grau M, Sala J, Masiá R, Pérez G, Roset P, Bielsa O, Vila J, Marrugat J, Rev Esp Cardiol 2007 60 349 356 (Pubitemid 46881540)
5. Rendimiento de la estimación del riesgo cardiovascular en España mediante la utilización de distintas funciones. Comín E, Solanas P, Cabezas C, Subirana I, Ramos R, Gené-Badía J, Cordón F, Grau M, Cabré-Vila JJ, Marrugat J, Rev Esp Cardiol 2007 60 693 702 (Pubitemid 47394947)
6. Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention. Grundy SM, Circulation 2008 117 569 573
7. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Law MR, Wald NJ, Rudnicka AR, BMJ 2003 326 1407 1408
8. Do statins have a role in primary prevention? An update. Therapeutics Letter Issue 77/ Mar-Apr 2010. Disponibe en: http://ti.ubc.ca/letter77
9. La prevención según el CEIP para la prevención cardiovascular: una valoración crítica. Miguel F, Merino A, Montero MJ, Rev Esp Salud Pública 2010 84 2 104 107
10. Trends in prescribing and utilization of statins and other lípid lowering drug across Europe 1997-2003. Walley T, Folino-Gallo P, Stephens P, Van Ganse E, Br J Clin Pharmacol 2005 59 5 564 573
11. Peiró S, Sanfelix Gimeno G, Ridao López M, Cervera CP, Revisión sistemática de evaluaciones económicas de las estatinas comercializadas en España Valencia: Fundación Instituto de Investigación en Servicios de Salud 2005
12. The inverse benefit law: how drug marketing undermines patient safety and public health. Brody H, Light DW, Am J Public Health 2011 101 3 399 404
13. Optimizing statin treatment for primary prevention of coronary artery disease. Hayward RA, Krumholz HM, Zulman DM, Timbie JW, Vijan S, Ann Intern Med 2010 152 69 77
14. Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study. Baena-Díez JM, Félix FJ, Grau M, Cabrera de León A, Sanz H, Leal M, Elosua R, Rodríguez-Pérez Mdel C, Guembe MJ, Torán P, Vega-Alonso T, Ortiz H, Pérez-Castán JF, Frontera-Juan G, Lapetra J, Tormo MJ, Segura A, Fernández-Bergés D, Marrugat J, DARIOS, Rev Esp Cardiol 2011 64 9 766 773
15. Overprescribing in lipid lowering agents. Quality and Safety in H. Smith MA, Cox E, Bartell JM, Care 2006 15 251 257
16. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, de Craen AJ, Knopp RH, Nakamura H, Ridker P, van Domburg R, Deckers JW, BMJ 2009 338 2376
17. Disease mongering in drug promotion: Do governments have a regulatory role? Mintzes B, PLoS Med 2006 3 4 198
18. Risks and benefits of omega3 fats for mortality, cardiovascular disease and cancer: a systematic review. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Davey Smith G, BMJ 2006 332 752 755 (Pubitemid 44365649)
19. Audit and Feedback: effects on professional practice and health care outcomes. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD, Cochrane Database Syst Rev 2006 2, CD000259
20. Effect of point-of-care computer reminders on physician behaviour: a systematic review. Shojania KG, Jennings A, Mayhew A, Ramsay C, Eccles M, Grimshaw J, CMAJ 2010 182 5 216 E225
21. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. Kawamoto K, Houlihan CA, Balas EA, Lobach DF, BMJ 2005 330 7494 765
22. Electronic medical record reminders and panel management to improve primary care of elderly patients. Loo TS, Davis RB, Lipsitz LA, Irish J, Bates CK, Agarwal K, Markson L, Hamel MB, Arch Intern Med 2011 171 17 1552 1558
23. Iglesias Pérez B, Cortés Pérez P, Fina Avilés F, Méndez Boo L, Ferran Mercadé M, Medina Peralta M, Serrano Carro B, Casajuana Brunet J, Calero Muñoz S, Morros Pedrós R, Amat Camats G, Indicador sintètic de qualitat assistencial (EQA) dels equips d'atenció primària 2008 [En línea] Barcelona: Institut Català de la Salut 2008 Disponible en: http://www.gencat.net/ics/ professionals/pdf/EQA-2008.pdf
24. Construction and validation of ascoring system for the selection of high-quality data in a Spanish populationprimary care database (SIDIAP). García-Gil Mdel M, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, Rodriguez J, Williams T, Van Staa T, Bolíbar B, Inform Prim Care 2011 19 3 135 145
25. Trials in primary care: statistical issues inthe design, conduct and evaluation of complex interventions. Lancaster GA, Campbell MJ, Eldridge S, Farrin A, Marchant M, Muller S, Perera R, Peters TJ, Prevost AT, Rait G, Stat Methods Med Res 2010 19 4 349 377
26. Baena Díez JM, Barcelo Colomer E, Ciurana Misol R, Franzi Sisó A, García Cerdán MR, Ríos Rodriguez MA, Ramos Blanes R, Solanas Saura P, Vilaseca Canals J, Colesterol i risc coronari. Barcelona: Institut Català de la Salut, 2009. Guies de pràctica clínica i material docent, núm. 1 Disponible en: http://www.gencat.cat/ics/professionals/guies/colesterol/colesterol.htm
27. Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio REGICOR. Marrugat J, Vila J, Baena-Díez JM, Grau M, Sala J, Ramos R, Subirana I, Fitó M, Elosua R, Rev Esp Cardiol 2011 64 385 394
28. SIDIAP database: electronic clinical records in Primary Care as a source of information for epidemiologic research. Bolíbar B, Fina F, Morros R, Garcia-Gil M, Hermosilla E, Ramos R, Rosell M, Rodriguez J, Medina M, Calero S, Prieto-Alhambra D, Med Clin 2012 138 14 617 621